ResearcherUniversity of Occupational and Environmental Health JapanActive in the last 2 years
Tsuyoshi Ueda
Matched on ORCID iD 0009-0002-7896-4822; OpenAlex author ID A5036178012. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2025: 1 paper · 2026: 3 papers
Papers 4
- Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-relevant outcomes in unresectable pancreatic… Co-author DOI 10.1007/s00520-026-11102-1↗
- Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a r… Co-author DOI 10.1186/s12876-026-05075-y↗
- Dynamic Nutritional Decline During the Diagnostic-to-Treatment Interval Is Associated with Treatment Resilience and Survival in Unresectable Pancreatic Ductal … Co-author DOI 10.3390/nu18121998↗
- Autoimmune Acquired Factor V Deficiency in a Patient With Pancreatic Cancer Complicated by Cholangitis: A Rare Coagulopathy With a Favorable Course. Co-author DOI 10.7759/cureus.87946↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masaru Harada · 4 shared papers, 2025–2026 · strength 1.15
- Paper Autoimmune Acquired Factor V Deficiency in a Patient With Pancreatic Cancer Complicated by Cholangitis: A Rare Coagulop… DOI 10.7759/cureus.87946↗
- Paper Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-rele… DOI 10.1007/s00520-026-11102-1↗
- Paper Dynamic Nutritional Decline During the Diagnostic-to-Treatment Interval Is Associated with Treatment Resilience and Sur… DOI 10.3390/nu18121998↗
- Nobuhiko Shinohara · 3 shared papers, 2026 · strength 0.82
- Paper Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-rele… DOI 10.1007/s00520-026-11102-1↗
- Paper Dynamic Nutritional Decline During the Diagnostic-to-Treatment Interval Is Associated with Treatment Resilience and Sur… DOI 10.3390/nu18121998↗
- Paper Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients … DOI 10.1186/s12876-026-05075-y↗
- Daiki Uchihara · 1 shared paper, 2026 · strength 0.26
- Yasuhisa Mori · 1 shared paper, 2026 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.